国泰海通证券股份有限公司关于聚胶新材料股份有限公司 增加闲置自有资金现金管理额度的核查意见 议，审议通过了《关于增加闲置自有资金现金管理额度的议案》，同意公司增加 闲置自有资金现金管理额度不超过人民币 50,000 万元（含本数）（或等值外币）， 有效期自第二届董事会第十七次会议审议通过之日起至 2025 年 12 月 31 日止， 在有效期内可循环滚动使用上述额度。本次增加闲置自有资金现金管理额度后， 公司闲置自有资金现金管理的额度合计为不超过人民币 100,000 万元（含本数） （或等值外币）。 一、本次增加闲置自有资金现金管理额度的基本情况 （一）投资目的 为提高资金使用效益、增加股东回报，在确保不影响公司正常经营和有效控 制风险的前提下，公司拟使用部分闲置的自有资金进行现金管理，以更好的实现 公司现金的保值增值，保障公司股东的利益。 （二）投资品种及安全性 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 聚胶新材料股份有限公司（以下简称"聚胶股份"或"公司"）首次公开发行股 票并在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳 证券交易所上市公司自律监管指引第 ...

Group 1: Business Impact and Market Position - The new hygiene standards (GB 15979-2024) will positively influence the company's product development and compliance, particularly in the hygiene product sector [1] - Major clients include Kimberly-Clark, Drylock, and Procter & Gamble, with significant market share and ongoing opportunities for expansion [2] - The company aims to enhance its international competitiveness and brand influence through continuous innovation and market expansion [10] Group 2: Financial Performance and Projections - In 2024, the company achieved a revenue of CNY 2.006 billion, a year-on-year increase of 23.27%, with domestic revenue at CNY 840 million (up 14.97%) and overseas revenue at CNY 1.166 billion (up 30.03%) [16] - The first quarter of 2025 saw a revenue of CNY 503 million, reflecting a 4.80% year-on-year growth, and a net profit of CNY 35.517 million, up 13.62% [16] - The company expects a sales revenue growth of no less than 10% in 2025 compared to 2024 [16] Group 3: Strategic Initiatives and Challenges - The company is focusing on enhancing its supply chain and operational efficiency to mitigate risks associated with international trade and geopolitical factors [10] - A significant loss of CNY 24.7157 million was reported for the Mexican subsidiary due to currency fluctuations and project delays [3] - The company is actively pursuing new product development in various sectors, including medical and maternal care, to diversify its offerings [5] Group 4: Shareholder Concerns and Market Sentiment - The company's stock price is currently below the issue price, attributed to various market factors, but management remains confident in long-term growth [10] - Shareholder actions, such as the reduction of holdings by original shareholders, are compliant with regulations and do not reflect a lack of confidence in the company's future [12] - The company emphasizes the importance of long-term investment and value creation, urging investors to consider the broader market context [11]

Core Viewpoint - The company, 聚胶新材料股份有限公司, is hosting a 2024 annual performance briefing on May 30, 2025, to communicate its operational performance and development strategy to investors [1][2]. Group 1: Meeting Details - The annual performance briefing is scheduled for May 30, 2025, from 15:00 to 17:00 [1]. - The meeting will be conducted online via the "价值在线" platform [1]. - Participants will include the Chairman, General Manager, Board Secretary, Financial Officer, Independent Director, and Sponsor Representative [1]. Group 2: Investor Participation - Investors can join the meeting through the provided website or by scanning a QR code [2]. - Questions can be submitted by investors before the meeting date, and the company will address common inquiries during the briefing [2]. Group 3: Contact Information - The contact person for inquiries is 廖燕桃, with a provided phone number, fax, and email for further communication [2].

一、说明会召开的时间、地点和方式 会议召开时间：2025 年 5 月 30 日（星期五）15:00-17:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络文字互动方式 证券代码：301283 证券简称：聚胶股份 公告编号：2025-038 聚胶新材料股份有限公司 关于举办 2024 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 聚胶新材料股份有限公司（以下简称"公司"）已于 2025 年 4 月 15 日在巨 潮资讯网上披露了《2024 年年度报告》及《2024 年年度报告摘要》。为便于广 大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定于 2025 年 5 月 30 日（星期五）15:00-17:00 在"价值在线"（www.ir-online.cn）举办 2024 年度业绩说明会，与投资者进行沟通和交流，广泛听取投资者的意见和建议。现 将有关事项公告如下： 会议召开时间：2025 年 5 月 30 日（星期五）15:00-17:00 会议召开方式：网络文字互动方式 会 ...

Summary of Key Points Core Viewpoint - Zheng Chaoyang, a shareholder of JuJiao Co., Ltd. (301283), plans to reduce his holdings by a total of up to 241,250 shares, which represents no more than 3.00% of the company's total share capital, due to personal financial arrangements [1]. Reduction Plan - The reduction will occur in two phases: up to 804,200 shares through centralized bidding within three months after 15 trading days from the announcement, and up to 1,608,400 shares through block trading within three months after three trading days from the announcement [1]. - The shares to be reduced are sourced from those issued prior to the company's initial public offering [1]. Pricing and Uncertainty - The reduction price will be determined based on market conditions [1]. - The execution of the reduction plan is subject to market conditions and the company's stock price, indicating a level of uncertainty regarding the implementation [1].

本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 证券代码：301283 证券简称：聚胶股份 公告编号：2025-037 聚胶新材料股份有限公司 关于股东减持股份计划预披露公告 股东郑朝阳先生保证向本公司提供的信息内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、本次减持计划的主要内容 1、拟减持的原因：股东个人资金安排。 2、拟减持的股份来源：公司首次公开发行前已发行的股份。 3、拟减持数量、占公司总股本的比例：计划减持股份不超过 2,412,534 股（即 不超过公司总股本的 3.00%）；若实施期间有送股、资本公积金转增股本、配股、 注销已回购股份等股份变动事项，拟减持股份数量将相应进行调整。 | 股东名称 | 持有股份的总数量（股） | 占公司总股本的比例 | | --- | --- | --- | | 郑朝阳 | 3,448,422 | 4.29% | 注：其首次公开发行前取得的股份已于 2023 年 9 月 15 日解除限售。 特别提示： 持有聚胶新材料股份有限公司（以下简称"公司"或"本公司"）股份 3,448,422 股（占本公司总股本比例 4.29%）的股东 ...

Group 1 - Qingmu Technology plans to reduce its shareholding by up to 3%, amounting to no more than 2.776 million shares [1] - Newcap received a decision from the police to revoke the case against its actual controller, who was previously detained for insider trading [2] - Rhine Biotech's directors and executives plan to collectively reduce their holdings by up to 0.14%, totaling no more than 1.0185 million shares [3] Group 2 - Puli Tui's stock and convertible bonds will be delisted on May 22, 2025 [5] - *ST Nong Shang will have its delisting risk warning lifted and will resume trading on May 23, 2025 [7] - State Grid Information Communication plans to acquire 100% equity of Yili Technology for approximately 1.853 billion yuan [9] Group 3 - Kelun Pharmaceutical's subsidiary received drug registration approval for a new injectable product, which is the first of its kind in China [10] - Aishida plans to acquire 7% equity of its subsidiary Zhejiang Qianjiang Robot Co., Ltd. for 13.09 million yuan [11] - Hongming Co. is planning to acquire 83% equity of Shenzhen Chisu Automation Equipment Co., Ltd. for approximately 151 million yuan [12] Group 4 - JuJiao Co. plans to reduce its shareholding by up to 2.6%, totaling no more than 2.093 million shares [14] - AVIC Financial's stock will be delisted on May 27, 2025 [16] - Jingwang Electronics' major shareholders plan to reduce their holdings by up to 2.99% [17] Group 5 - Huaren Health intends to acquire stakes in three pharmaceutical chain companies for a total of 327 million yuan [18] - Huanrui Century's original shareholders are required to compensate for unfulfilled performance commitments with 116 million shares [20] - Tefa Service's shareholders plan to reduce their holdings by up to 3% [21] Group 6 - Maipu Medical is planning to acquire at least 51% of Easy Medical's equity, which will constitute a major asset restructuring [22] - *ST Jinshi will have its delisting risk warning lifted and its stock will resume trading on May 23, 2025 [22] - Guoke Micro is planning a major asset restructuring and will suspend trading [23] Group 7 - Defu Technology intends to acquire 100% equity of an overseas electronic circuit copper foil company [24] - Xince Standard's shareholder plans to reduce its holdings by up to 1% [25] - Xiouqiang Co. plans to reduce its holdings by up to 3% [27]

Group 1 - The State Financial Supervision Administration and seven other departments issued measures to support financing for small and micro enterprises, emphasizing the establishment of a coordination mechanism for financing support [1] - The measures include conducting extensive visits to small and micro enterprises to assess their operational status and financing needs, facilitating direct access to bank credit [1] - There is a focus on addressing the operational difficulties faced by small and micro enterprises and encouraging support for key sectors such as foreign trade, private enterprises, technology, and consumption [1] Group 2 - In May 2025, a total of 130 domestic online games were approved by the National Press and Publication Administration [2] Group 3 - The State Council announced the removal of Wang Jianjun from the position of Vice Chairman of the China Securities Regulatory Commission [3] Group 4 - The Shanghai Municipal Government issued a plan to boost consumption, which includes measures to promote reasonable income growth and improve wage distribution mechanisms [4] - The plan aims to enhance the minimum wage adjustment mechanism and support the development of the rural economy and new business models [4] Group 5 - Shanghai is accelerating the introduction of childcare subsidies and maternity social security subsidies as part of its efforts to build a family-friendly society [5] - The city plans to explore increasing parental leave and spouse's paternity leave while enhancing the quality of public kindergartens [5] Group 6 - The Ministry of Foreign Affairs stated that China has the capability and confidence to handle external risks, including tariff wars, as evidenced by a 2.4% year-on-year increase in total goods import and export in the first four months of the year [6] - Exports grew by 7.5%, indicating strong international competitiveness despite high tariff barriers [6] Group 7 - The Ministry of Foreign Affairs expressed strong opposition to the EU's unilateral sanctions against Chinese companies, emphasizing the need for fair trade practices [8] - The ministry highlighted that normal business interactions between Chinese and Russian companies should not be disrupted by these sanctions [8] Group 8 - The Dalian Commodity Exchange announced trading arrangements for the Dragon Boat Festival period, with a market closure from May 31 to June 2, 2025, and a return to normal trading on June 3 [9] Group 9 - Heng Rui Pharmaceutical set the issuance price for its H-shares at HKD 44.05 per share [11] - Xinyuan Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [11] - The company Guokai Microelectronics is planning a major asset restructuring, leading to a suspension of its stock from May 22 [11]

Key Points - Vanke A has signed a supplementary agreement with Shenzhen Metro Group for a loan of up to 4.2 billion yuan, with a pledge of up to 6 billion yuan in shares of its subsidiary, Wanwu Cloud [3] - Heng Rui Pharmaceutical has set the final price for its H-share issuance at 44.05 HKD per share, with plans to list on the Hong Kong Stock Exchange on May 23, 2025 [4] - Wan Dong Medical has elected Ma Chibing as the new chairman after Hu Ziqiang resigned from the position [5] - Tianqi Mould has confirmed that there are no undisclosed significant matters amid ongoing major asset restructuring [6] - Zhejiang Rongtai plans to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - ST Mingcheng intends to publicly transfer 45% of its subsidiary, Time Media, which will no longer be included in the consolidated financial statements [8] - Shanghai Xiba plans to purchase patent assets for 2 million yuan and 500,000 yuan, and establish subsidiaries to promote the commercialization of new technologies [9] - Jushen Co. has received a total of 95.7 million yuan in dividends from its six wholly-owned subsidiaries [10] - ST Asia Pacific has confirmed no undisclosed significant matters or ongoing major plans [11] - Tianrong Tianyu's controlling shareholder's agreement will not be renewed after its expiration [12] - Wangzi New Materials has stated that its energy storage capacitor business is minimal and will not significantly impact its performance [13] - Nanjing Port has clarified that its foreign trade container business does not have direct routes to the U.S. [14] - Jinlongyu has indicated that its solid-state battery business has not yet formed stable long-term revenue [15] - Tianzhihang's subsidiary plans to raise capital by introducing investors [16] - State Grid Information plans to acquire 100% of Yili Technology for 1.853 billion yuan, enhancing its revenue and profit [17] - ST Nongsang will remove its delisting risk warning starting May 23 [18] - Yipin Hong has stated that its innovative drug AR882 has not yet been launched and will not significantly impact recent performance [19] - Huanrui Century has announced a performance compensation plan requiring original shareholders to compensate 116 million shares [20] - Huaren Health plans to acquire stakes in three pharmaceutical chain companies for a total of 3.282 billion yuan [21][22] - Hongming Co. is planning to acquire 83% of Shenzhen Chisu for 1.51 billion yuan [23] - Aishida intends to acquire an additional 7% stake in its subsidiary Qianjiang Robot for 13.09 million yuan [24] - Dasheng Intelligent has signed a contract worth 11.5 million yuan for a high-efficiency machine room project [25] - Jinggu Co. has received a notice to supply wheels for a major global automaker, with expected sales of approximately 158 million USD over ten years [26] - Pingzhi Information has signed a framework agreement with China Mobile for antenna products worth up to 13.01 million yuan [27] - Shanghai Laishi's controlling shareholder plans to increase its stake by 250 million to 500 million yuan [28] - Qixia Construction's shareholder plans to reduce its stake by up to 3% [29] - Sichuan Gold's major shareholders plan to reduce their stakes by up to 5.5% [30] - Qingyun Technology's shareholders plan to reduce their stakes by up to 4.5% [31] - Rhein Biological's directors plan to reduce their stakes by up to 0.14% [32] - Qingmu Technology's shareholder plans to reduce its stake by up to 3% [33] - Sanrenxing's employee shareholding platform plans to reduce its stake by up to 3% [34][35] - Juzhi Technology's director plans to reduce his stake by up to 40,000 shares [36] - Jingwang Electronics' major shareholders plan to reduce their stakes by up to 2.99% [37] - Jujiao Co. plans to reduce its stake by up to 2.6% [38] - Xiyu Tourism's major shareholder plans to reduce its stake by up to 3% [39]

股东名称 持有股份的总数量（股） 占公司总股本的比例 科金聚创 2,093,023 2.60% 证券代码：301283 证券简称：聚胶股份 公告编号：2025-036 聚胶新材料股份有限公司 股东广州科金聚创创业投资合伙企业（有限合伙）保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有聚胶新材料股份有限公司（以下简称"公司"或"本公司"）股份 2,093,023 股（占本公司总股本比例 2.60%）的股东广州科金聚创创业投资合伙企业（有限 合伙）计划自本减持计划公告之日起 15 个交易日后的 3 个月内通过集中竞价交 易方式减持本公司股份不超过 804,178 股（即不超过公司总股本的 1.00%）或自 本减持计划公告之日起 3 个交易日后的 3 个月内通过大宗交易方式减持本公司 股份不超过 1,608,356 股（即不超过公司总股本的 2.00%），合计减持不超过 公司于近日收到股东广州科金聚创创业投资合伙企业（有限合伙）（以下简 称"科金聚创"）出具的《关于股份减持计划的告知函》。现将相关 ...